(68) found that GLS in combination with serum Gal-3 testing could noninvasively screen for subclinical LVDD in patients with asymptomatic DM, with patients with preserved EF having significantly higher Gal-3 levels and lower GLS values compared with patients with DM alone. Here, LGALS3 is linked to diabetes mellitus.